logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Lubbe Wiesner

University of Cape Town
H指数:40
被引数:5,951

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacokinetics of Efavirenz in Pregnancy and Postpartum with and Without First-line Tuberculosis Drugs: Results from IMPAACT P1026s

妊娠及产后期间使用和不使用一线结核病药物时依非韦伦的药代动力学：IMPAACT P1026s研究结果

Clinical Pharmacokinetics
IF4
2026-10-030
OA
Marije Van Schalkwyk; Jiajia Wang; Adrie Bekker; Eric Decloedt; Gerhard B. Theron; Mark F. Cotton; Tim R. Cressey; Deo Wabwire; Chelsea Stotz; Kevin Knowles; Kathleen George; Renee Browning; Kittipong Rungruengthanakit; Lubbe Wiesner; Edmund V. Capparelli; Alice M. Stek; Mark Mirochnick; David E. Shapiro; Brookie M. Best; Ahizechukwu C. Eke
Pharmacokinetics of clofazimine tablet formulation in children with rifampicin-resistant tuberculosis in CATALYST, a multi-site international trial

在CATALYST多中心国际试验中，利福平耐药结核患儿氯法齐明片剂制剂的药代动力学

Journal of the Pediatric Infectious Diseases Society
IF2.6
2026-09-090
OAAI
Yuanxi Zou; Megan Palmer; Melchor V G Frias; Dessa Jean O Casalme; Aarti A Kinikar; Mandar Paradkar; Vandana Kulkarni; Pragathi Kamath; Ingrid Courtney; Heather Draper; Lubbe Wiesner; Mats O Karlsson; Paolo Denti; Louvina van der Laan; Anthony J Garcia-Prats; Anneke C Hesseling; Elin M Svensson; null
The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in HIV-associated Tuberculosis

利福平对HIV相关结核病患者中替诺福韦艾拉酚胺富马酸酯血浆及细胞内药代动力学的影响

JAIDS-Journal of Acquired Immune Deficiency Syndromes
IF2.2
2026-04-010
PRE
Mpofu, Rephaim; Chandiwana, Nomathemba; Sokhela, Simiso; Moorhouse, Michelle; Venter, Francois; Anderson, Peter L.; Wiesner, Lubbe; Boffito, Marta; Maartens, Gary; Sinxadi, Phumla
Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and Rifampicin
Clinical Infectious Diseases
IF7.3
2025-12-300
OAAI
Emmanuella Chinonso Osuala; Ivan Nicholas Nkuhairwe; Marothi Peter Letsoalo; Kogieleum Naidoo; Rubeshan Perumal; James F Rooney; Lubbe Wiesner; Roeland E Wasmann; Paolo Denti; Kelly E Dooley; Anushka Naidoo; ; Anushka Naidoo; Kelly E Dooley; Kogieleum Naidoo; Gillian Dorse; Rubeshan Perumal; Resha Boodhram; Busisiwe Ntsalaze; Samiksha Byroo; Ellisha Francis; Anokhee Leela; Rosemary Gray; Bhavna Maharaj; Nompumelelo Zungu; Phindile Msomi; Claudia Shozi; Radhamoney Narasimmulu; Nokuzola Cwazibe; Rajesperi Venter; Saras Pather; Nokwanda Depargo; Silindile Tenza; Patience Mbatha; Marothi Letsoalo; Mxolisi Mahlangu; Natasha Samsunder; Zanele Mchunu; Avanthi Moodley-Reddy; Lungile Maphumulo; Adejumoke Abiose; Emmanuella Chinonso Osuala
Fixed-dose combination bictegravir–emtricitabine–tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial

固定剂量联合制剂bictegravir–emtricitabine–tenofovir alafenamide每日两次用于利福平基线结核病治疗期间的HIV治疗（INSIGHT研究）：一项2b期、开放标签、随机非对照试验

The Lancet HIV
IF0
2025-12-010
PRE
Anushka Naidoo; Kogieleum Naidoo; Marothi P Letsoalo; Roeland E Wasmann; Gillian Dorse; Rubeshan Perumal; Mahomed-Yunus S Moosa; Emmanuella C Osuala; Resha Boodhram; Benjamin Chimukangara; Lubbe Wiesner; Dennis Israelski; Paolo Denti; James F Rooney; Kelly E Dooley
Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020-2021

2020-2021年布基纳法索地区使用青蒿琥酯-苯芴醇、双氢青蒿素-哌喹、青蒿素-哌喹三联疗法治疗无并发症恶性疟原虫疟疾的疗效研究

MALARIA JOURNAL
IF3
2025-12-010
PRE
Gansane, Adama; Tarama, Casimir; Lingani, Moussa; Debe, Siaka; Tiendrebeogo, Farida; Kinda, Rene; Sagnon, Aladari; Ganou, Adama; Rouamba, Toussaint; Sombie, Salif; Some, Henri; Kiendrebeogo, Seraphine; Bonko, Massa A.; Tougri, Gauthier; Kompaore, Christian S.; Wiesner, Lubbe; Eddis, Charlotte; Horton, Breanna; Kennedy, Culzean; Bajic, Marko; Pierre-Louis, Edwin; Kahn, Adam; Rosillo, Stefano; Patel, Dhruviben S.; Mccaffery, Jessica N.; Plucinski, Mateusz M.; Laird, Veronika; Ahmed, Jehan; Tinto, Halidou; Valea, Innocent; Moriarty, Leah F.
Bridging to Paediatric Dosing: Relative Bioavailability of Suspended Rifapentine and Isoniazid in an Open-Label Randomized Trial in Adults on Tuberculosis Preventive Therapy

桥接至儿科剂量：悬浮利福平和异烟肼的相对生物利用度——一项在结核病预防治疗成人中进行的开放标签随机试验

Clinical Pharmacokinetics
IF4
2025-10-110
OA
Saskia Janssen; Thanakorn Vongjarudech; Mats O. Karlsson; Caryn M. Upton; Anthony J. Garcia-Prats; Andreas H. Diacon; Lubbe Wiesner; Tina Sachs; Louvina E. van der Laan; Nicole Salazar-Austin; Anneke C. Hesseling; Elin M. Svensson
Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s

氯法齐明在利福平耐药结核病孕妇及产后妇女中的药代动力学与安全性：IMPAACT P1026s研究的结果

JOURNAL OF INFECTIOUS DISEASES
IF4.5
2025-10-010
PRE
Hughes, Jennifer A.; Mcmorrow, Flynn; Brooks, Kristina M.; Pinilla, Mauricio; Fairlie, Lee; Ngocho, James S.; Stek, Alice; Best, Brookie M.; Mirochnick, Mark; Wiesner, Lubbe; George, Kathleen; Knowles, Kevin; Browning, Renee; Deyampert, Tara; Hesseling, Anneke C.; Decloedt, Eric; Shapiro, David E.; Eke, Ahizechukwu C.
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa

一项横断面研究，评估在肯尼亚、津巴布韦、斯威士兰和南非开展的替诺福韦二吡呋酯为基础的暴露前预防项目中，被诊断为HIV-1感染者中HIV耐药突变的发生频率。

Journal of the International AIDS Society
IF4.9
2025-08-200
OA
Urvi M. Parikh; Lauren D. Kudrick; Lisa Levy; Everline Bosek; Bhavna H. Chohan; Irene Mukui; Sarah Masyuko; Nonhlanhla Ndlovu; Imelda Mahaka; Owen Mugurungi; Gertrude Ncube; Anita Hettema; Sindy N. Matse; Saiqa Mullick; Carole L. Wallis; Amy L. Heaps; Kerri J. Penrose; Kevin D. McCormick; Lubbe Wiesner; Peter L. Anderson; Jill M. Peterson; Connie Celum; Barbra A. Richardson; Delivette Castor; Shannon Allen; Kristine Torjesen; John W. Mellors; Global Evaluation of Microbicide Sensitivity (GEMS) Project
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial

同时启动以多替阿巴拉韦为基础的抗逆转录病毒治疗和每周一次利福平肼和异烟肼用于结核病预防在抗逆转录病毒初治的HIV感染者中的研究：一项开放标签、非随机、1/2期临床试验

lancet hiv
IF0
2025-05-080
PRE
Ethel D Weld; Trevor Beattie; Jayajothi Moodley; Manasa Mapendere; Isadora Salles; Belén P Solans; Bareng A S Nonyane; Lubbe Wiesner; Tanya Nielson; Vinodh A Edward; Violet Chihota; Radojka M Savic; Kelly E Dooley; Richard E Chaisson; Gavin J Churchyard; ;
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s

左氧氟沙星治疗利福平耐药结核病在孕期及产褥期的药代动力学与安全性：IMPAACT P1026s研究的结果

CLINICAL PHARMACOKINETICS
IF4
2025-03-280
OA
Hughes, Jennifer A.; Pinilla, Mauricio; Brooks, Kristina M.; Eke, Ahizechukwu C.; Stek, Alice; Best, Brookie M.; Mirochnick, Mark; Browning, Renee; Wiesner, Lubbe; George, Kathleen; Knowles, Kevin; De Koker, Petra; Ngocho, James S.; Fairlie, Lee; Chakhtoura, Nahida; Hesseling, Anneke C.; Decloedt, Eric; Shapiro, David E.; van Schalkwyk, Marije
Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
2025-02-170
OA
Palmer, Megan; Zou, Yuanxi; Hesseling, Anneke C.; van Der Laan, Louvina; Courtney, Ingrid; Kinikar, Aarti A.; Sonkawade, Naresh; Paradkar, Mandar; Kulkarni, Vandana; Casalme, Dessa Jean O.; Frias, Melchor V. G.; Draper, Heather; Wiesner, Lubbe; Karlsson, Mats O.; Denti, Paolo; Svensson, Elin M.; Garcia-Prats, Anthony J.

研究方向

暂未获取到该数据
P
Paolo Denti
H 指数:36论文数:245被引数:4,362
H
Helen McIlleron
H 指数:54论文数:251被引数:9,691
G
Gary Maartens
H 指数:78论文数:584被引数:2.2万
A
Anneke C. Hesseling
H 指数:62论文数:403被引数:1.5万
S
Sandra Castel
H 指数:12论文数:40被引数:655
J
Jennifer Norman
H 指数:27论文数:113被引数:2,074
K
Kelly E. Dooley
H 指数:48论文数:232被引数:9,262
A
Anthony J. Garcia‐Prats
H 指数:29论文数:147被引数:2,652
H
H. Simon Schaaf
H 指数:75论文数:466被引数:2.2万
R
Richard Court
H 指数:13论文数:41被引数:507